Bioceres reports fiscal 2026 fourth-quarter results

Bioceres Crop Solutions reported on 14 September 2026 that revenues from continuing operations reached $55.9 million in its fiscal fourth quarter ended 30 June 2026. The figure remained broadly stable year-over-year, supported by 36% growth in Crop Nutrition that offset lower Crop Protection sales and the reconfiguration of its Seeds unit. Full-year revenue dropped 18% to $238.3 million, with roughly half of the decline tied to the Seeds revamp and reduced HB4-related activities.

Gross profit for the fourth quarter fell to $12.7 million from $13.6 million a year earlier, affected by a $4.0 million non-recurring inventory obsolescence adjustment. For the full year, gross profit declined 21% to $82.9 million due to higher obsolescence charges and lower inoculant contributions, including reduced revenue from the Syngenta agreement. The company classified its Pro Farm Group unit as discontinued operations following a January 2026 foreclosure auction that remains under legal dispute.

Operating cost controls lowered selling, general, and administrative expenses by 19% in the quarter to deliver a $4.9 million reduction. Full-year SG&A fell 24% to $71.2 million, saving $22.5 million. The lower cost base helped fourth-quarter Adjusted EBITDA recover to positive $0.6 million from negative $9.6 million, while the quarterly net loss from continuing operations narrowed to $31.8 million from $54.4 million. For the full year, net loss from continuing operations widened to $54.4 million from $49.1 million, and Adjusted EBITDA ended at $25.5 million compared to $28.9 million in fiscal 2025.